Press release
Global Pharyngitis Market Scenario Highlighting Major Drivers & Trends, 2017-2026 | Key Players are GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals Inc., etc.
Get a Free Sample Report from Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=361
Pharyngitis commonly known as a sore throat is caused by viral or bacterial infection. The most common bacteria infecting throat is Group a streptococcus. Various clinical trials are being carried on to find the best formulation effective in treating sore throat. There is also a focus on patients receiving medication as per the clinical needs and also meet their individual requirement. The healthcare industry across the globe is also emphasizing on appropriate diagnosis, drug selection, dosage, and drug delivery route, duration of administration, proper follow-up, and correct information on possible side-effects. The latest study by FactMR expects the global market for pharyngitis to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue. Pharyngitis is the most common manifestation of infection. Antibiotics are given in case of a sore throat, however, they provide very modest benefit. It is still unclear which antibiotic is the best for the treatment of a sore throat. Hence, various research and trials are being conducted to find most effective antibiotic.
Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their use.
Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain.
Oral drug delivery is likely to emerge as the most-preferred drug administration route. Oral drug delivery is projected to create an incremental opportunity of over US$ 300 million between 2017 and 2026. Owing to the cost-effectiveness, convenience and high patient compliance, oral drug delivery is witnessing significant growth. However, many drugs are poorly bioavailable when administered. Hence, lipid-based drug delivery system is one of the emerging trends addressing bioavailability challenges. Moreover, oral drug delivery is the least invasive method as compared to other routes. Targeted drug delivery is also an emerging trend, in which the drug is active only in the targeted area.
Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=361
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global pharyngitis market through 2026, which include Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals, Inc., and Zambon Group SpA.
Table of Content:
Global Economic Outlook
Global Pharyngitis Market - Executive Summary
Global Pharyngitis Market Overview
3.1. Introduction
3.1.1. Global Pharyngitis Market Taxonomy
3.1.2. Global Pharyngitis Market Definition
Continued………………………
Contact Us
FactMR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
About FactMr
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharyngitis Market Scenario Highlighting Major Drivers & Trends, 2017-2026 | Key Players are GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals Inc., etc. here
News-ID: 1821702 • Views: …
More Releases from Fact.MR
Halloumi Cheese Market Surges Past US$ 1.2 Billion Mark by 2033, Fueled by 10.4% …
It is anticipated that halloumi cheese market will be valued at US$ 445 million in 2023 and surpass US$ 1.2 billion by the end of 2033. It is projected that the worldwide market for halloumi cheese will grow at an astounding rate of 10.4% CAGR till 2033.
Cyprus, a Middle Eastern nation, is the birthplace of halloumi cheese, which has been made there by local farmers for generations. Since this nation…
Cheese Market Is Anticipated To Reach US$ 133 Billion At A CAGR Of 3.7% By 2032: …
In 2022, the global cheese market held a value of US$ 92 billion, with projections indicating a substantial growth trajectory. By the end of 2032, it is anticipated to soar to US$ 133 billion, according to a study conducted by Fact.MR. The research suggests that the worldwide demand for cheese is expected to experience a steady increase, with a compound annual growth rate (CAGR) of 3.7% forecasted through the year…
Product Engineering Services Market Is Set To Reach A Valuation Of US$ 2,400 Bil …
As of 2023, the global market for product engineering services reached a valuation of US$ 1,200 billion, with a projected growth to US$ 2,400 billion by the end of 2033. Forecasts indicate a steady increase in global demand for these services, with a compound annual growth rate (CAGR) expected to reach 7.2% from 2023 to 2033.
The Product Engineering Services Industry sales study offers a comprehensive analysis on diverse features including…
Golf Shoes Market Is Anticipated To Reach US$ 13,331.7 Million By 2032: Fact.MR …
In 2022, the worldwide golf shoes market is projected to be valued at US$ 8,584.1 million. It's anticipated to grow steadily at a compound annual growth rate (CAGR) of 4.4%, reaching US$ 13,331.7 million by 2032.
The Golf Shoes Industry sales study offers a comprehensive analysis on diverse features including production capacities, Golf Shoes demand, product developments, sales revenue generation and Golf Shoes market outlook across the globe.
market research report by…
More Releases for Pharyngitis
Pharyngitis Market Future Forecast Indicates Impressive Growth Rate
Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore…
Pharyngitis Therapeutics Market by Source of Infection Viral and Bacterial
According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious lack of new…
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and…
Researchers Discover Potential of Pharyngitis Therapeutics Market
Pharyngitis Therapeutics Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Pharyngitis Therapeutics Market research report is a professional and in-depth study on the current state of Pharyngitis Therapeutics Industry.
The Pharyngitis Therapeutics Market research report covers the present scenario and the growth prospects of…
Pharyngitis Market Projected to Gain Significant Value by 2026
A sore throat or pharyngitis is caused when a virus infects the area of the throat. Some of the most common causes of pharyngitis is viral infections such as the influenza and common cold. Acute pharyngitis is one of the most common condition, hence, there has been an increase in demand for systematic treatment and medication. Drug manufacturers are also focusing on research and development of new drugs to treat…
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis Therapeutics Market Dynamics
According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious…
